Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sinopharm Tech HoldingsHKSE:08156 -2.50%27 Days Inventory is 72.31 as of Dec. 2025, which is 115% above its 10-year median of 33.69. GuruFocus rates HKSE:08156 with a GF Score™ of 27/100 and a GF Value™ of HK$0.06 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,666 Software companies, Sinopharm Tech Holdings ranks worse than 75.03% on this metric.
The historical rank and industry rank for Sinopharm Tech Holdings's Days Inventory or its related term are showing as below:
HKSE:08156'
s Days Inventory Range Over the Past 10 Years
Min: 5.79 Med: 33.69 Max: 380.13
Current: 72.78
During the past 13 years, Sinopharm Tech Holdings's highest Days Inventory was 380.13. The lowest was 5.79. And the median was 33.69.
HKSE:08156's Days Inventory is ranked worse than 75.03% of 1666
companies
in the Software industry
Industry Median: 19.74
vs HKSE:08156: 72.78
Sinopharm Tech Holdings's Days Inventory
declined
from Dec. 2024 (147.81) to Dec. 2025 (72.31).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sinopharm Tech Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.52.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sinopharm Tech Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.32.
Sinopharm Tech Holdings (HKSE:08156) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sinopharm Tech Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sinopharm Tech Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sinopharm Tech Holdings Days Inventory Related Terms
Sinopharm Tech Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08156 vs QH, SHOP, UBER: Days Inventory Comparison
For the Software - Application subindustry, Sinopharm Tech Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Tech Holdings Days Inventory vs Software Industry
For the Software industry and Technology sector, Sinopharm Tech Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sinopharm Tech Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Tech Holdings (HKSE:08156) has a Days Inventory of 72.31 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sinopharm Tech Holdings and its competitors. This is 115% above median its historical median of 33.69. Over the past decade, Sinopharm Tech Holdings' Days Inventory has ranged from 5.79 to 380.13. According to the industry distribution chart, Sinopharm Tech Holdings ranks #1250 out of 1666 companies in the Software industry, placing it in the top 75%.
Is Sinopharm Tech Holdings' Days Inventory too high?
Sinopharm Tech Holdings' current Days Inventory of 72.31 is 115% above median its 10-year median of 33.69. Over the past 10 years, this metric has ranged from a low of 5.79 to a high of 380.13. The Software industry median Days Inventory is 19.74. Sinopharm Tech Holdings' value of 72.31 is 266.3% above this industry median. Based on the distribution chart, Sinopharm Tech Holdings ranks #1250 out of 1666 companies in the Software industry, which is below the industry midpoint. Overall, Sinopharm Tech Holdings has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Tech Holdings' Days Inventory compare to QH and SHOP?
According to the Software industry distribution chart, Sinopharm Tech Holdings ranks #1250 out of 1666 companies for Days Inventory. This places Sinopharm Tech Holdings in the lower half of its industry. The industry median Days Inventory is 19.74. Sinopharm Tech Holdings' value of 72.31 is 266.3% above this benchmark. Historically, Sinopharm Tech Holdings' own Days Inventory has ranged from 5.79 to 380.13 over the past decade. While the company's 10-year median is 33.69 vs. the industry median of 19.74, Sinopharm Tech Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Software company?
The median Days Inventory among Software companies is 19.74, based on 1,666 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sinopharm Tech Holdings's current Days Inventory of 72.31 is 266.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sinopharm Tech Holdings and its competitors. For the Software industry, the median Days Inventory is 19.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinopharm Tech Holdings's current Days Inventory is 72.31, which is 115% above median its own 10-year median of 33.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Tech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Tech Holdings (HKSE:08156) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.16 — trading 160% above its estimated fair value. The current Days Inventory is 72.31, which is 115% above median its 10-year median of 33.69 and 266.3% above the Software industry median of 19.74. Sinopharm Tech Holdings' overall GF Score™ is 27/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sinopharm Tech Holdings (HKSE:08156), the current Days Inventory is 72.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Tech Holdings (HKSE:08156) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Tech Holdings stock appears to be overvalued.
The current stock price of HK$0.16 is trading 160% above its estimated GF Value™ of HK$0.06.
GuruFocus considers Sinopharm Tech Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:08156:
Days Inventory: 72.31 (115% above median its 10-year median of 33.69)
GF Value™: HK$0.06 vs. price of HK$0.16 (160% above fair value)
Industry Position: 266.3% above the Software median (#1250 of 1666)
No single metric tells the full story. See the HKSE:08156 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sinopharm Tech Holdings Ltd is an investment holding company operating through three segments: Internet Plus services, Supply Chain services, and Manufacturing and distribution of personal protective equipment. The company generates the majority of its revenue from the Supply Chain services segment, which includes supply chain management, data analysis, and trading of medical and related products. Geographically, it operates in Hong Kong and the People's Republic of China (PRC), with the majority of its revenue coming from the PRC.
27GF Score
Get the complete analysis for HKSE:08156
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08156 has been successfully added to your 
